nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—Stiffness—Hydrochlorothiazide—nephrolithiasis	0.067	0.109	CcSEcCtD
Tranylcypromine—CYP2C19—urine—nephrolithiasis	0.0476	0.124	CbGeAlD
Tranylcypromine—CYP1A2—urine—nephrolithiasis	0.0389	0.101	CbGeAlD
Tranylcypromine—CYP2C9—urine—nephrolithiasis	0.0369	0.0961	CbGeAlD
Tranylcypromine—CYP2E1—urine—nephrolithiasis	0.035	0.091	CbGeAlD
Tranylcypromine—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0307	0.0499	CcSEcCtD
Tranylcypromine—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0294	0.0477	CcSEcCtD
Tranylcypromine—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0284	0.0461	CcSEcCtD
Tranylcypromine—CYP3A4—urine—nephrolithiasis	0.0282	0.0732	CbGeAlD
Tranylcypromine—CYP2D6—urine—nephrolithiasis	0.0277	0.0721	CbGeAlD
Tranylcypromine—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0174	0.0282	CcSEcCtD
Tranylcypromine—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0148	0.024	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0147	0.0239	CcSEcCtD
Tranylcypromine—MAOB—nephron tubule—nephrolithiasis	0.0147	0.0383	CbGeAlD
Tranylcypromine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0222	CcSEcCtD
Tranylcypromine—MAOB—renal system—nephrolithiasis	0.0134	0.0348	CbGeAlD
Tranylcypromine—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.0133	0.0216	CcSEcCtD
Tranylcypromine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.013	0.0211	CcSEcCtD
Tranylcypromine—MAOB—kidney—nephrolithiasis	0.0129	0.0336	CbGeAlD
Tranylcypromine—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0208	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0207	CcSEcCtD
Tranylcypromine—MAOB—cortex of kidney—nephrolithiasis	0.0126	0.0327	CbGeAlD
Tranylcypromine—MAOA—nephron tubule—nephrolithiasis	0.0125	0.0326	CbGeAlD
Tranylcypromine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0194	CcSEcCtD
Tranylcypromine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0193	CcSEcCtD
Tranylcypromine—MAOA—renal system—nephrolithiasis	0.0114	0.0297	CbGeAlD
Tranylcypromine—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0184	CcSEcCtD
Tranylcypromine—MAOA—kidney—nephrolithiasis	0.011	0.0287	CbGeAlD
Tranylcypromine—MAOA—cortex of kidney—nephrolithiasis	0.0107	0.0279	CbGeAlD
Tranylcypromine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0174	CcSEcCtD
Tranylcypromine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0105	0.017	CcSEcCtD
Tranylcypromine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0169	CcSEcCtD
Tranylcypromine—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0167	CcSEcCtD
Tranylcypromine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0166	CcSEcCtD
Tranylcypromine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00998	0.0162	CcSEcCtD
Tranylcypromine—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00997	0.0162	CcSEcCtD
Tranylcypromine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00984	0.016	CcSEcCtD
Tranylcypromine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00978	0.0159	CcSEcCtD
Tranylcypromine—CYP1A2—renal system—nephrolithiasis	0.00952	0.0248	CbGeAlD
Tranylcypromine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00945	0.0153	CcSEcCtD
Tranylcypromine—CYP2E1—nephron tubule—nephrolithiasis	0.00942	0.0245	CbGeAlD
Tranylcypromine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00927	0.0151	CcSEcCtD
Tranylcypromine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00916	0.0149	CcSEcCtD
Tranylcypromine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00909	0.0148	CcSEcCtD
Tranylcypromine—Shock—Hydrochlorothiazide—nephrolithiasis	0.00894	0.0145	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.0089	0.0144	CcSEcCtD
Tranylcypromine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00887	0.0144	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00878	0.0143	CcSEcCtD
Tranylcypromine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00866	0.0141	CcSEcCtD
Tranylcypromine—CYP2E1—renal system—nephrolithiasis	0.00856	0.0223	CbGeAlD
Tranylcypromine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00849	0.0138	CcSEcCtD
Tranylcypromine—CYP2E1—kidney—nephrolithiasis	0.00828	0.0215	CbGeAlD
Tranylcypromine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00822	0.0133	CcSEcCtD
Tranylcypromine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00816	0.0133	CcSEcCtD
Tranylcypromine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00808	0.0131	CcSEcCtD
Tranylcypromine—CYP2E1—cortex of kidney—nephrolithiasis	0.00806	0.021	CbGeAlD
Tranylcypromine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0079	0.0128	CcSEcCtD
Tranylcypromine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00777	0.0126	CcSEcCtD
Tranylcypromine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00777	0.0126	CcSEcCtD
Tranylcypromine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00749	0.0122	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00743	0.0121	CcSEcCtD
Tranylcypromine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00722	0.0117	CcSEcCtD
Tranylcypromine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00718	0.0117	CcSEcCtD
Tranylcypromine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00718	0.0117	CcSEcCtD
Tranylcypromine—CYP3A4—renal system—nephrolithiasis	0.00689	0.0179	CbGeAlD
Tranylcypromine—CYP2D6—renal system—nephrolithiasis	0.00678	0.0176	CbGeAlD
Tranylcypromine—CYP3A4—kidney—nephrolithiasis	0.00666	0.0173	CbGeAlD
Tranylcypromine—CYP2D6—kidney—nephrolithiasis	0.00655	0.017	CbGeAlD
Tranylcypromine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00652	0.0106	CcSEcCtD
Tranylcypromine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00622	0.0101	CcSEcCtD
Tranylcypromine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00601	0.00976	CcSEcCtD
Tranylcypromine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00578	0.00938	CcSEcCtD
Tranylcypromine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00573	0.0093	CcSEcCtD
Tranylcypromine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00572	0.0093	CcSEcCtD
Tranylcypromine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00569	0.00924	CcSEcCtD
Tranylcypromine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0054	0.00877	CcSEcCtD
